Ramelteon (Rozerem) for Insomnia
Ramelteon (Rozerem - Takeda), a melatonin receptor agonist, has been approved by the FDA for treatment of insomnia characterized by difficulty falling asleep. Unlike all other prescription hypnotics, which are classified as schedule IV drugs, ramelteon is not a controlled substance....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Ramelteon (Rozerem) for Insomnia
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1221
Article Code: 1221a
Date: November 7, 2005
Volume: 47
Pages: 89-91
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1221
Article Code: 1221a
Date: November 7, 2005
Volume: 47
Pages: 89-91
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)